Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

This study has been completed.
Information provided by:
Stanford University Identifier:
First received: September 13, 2005
Last updated: July 27, 2009
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2009
  Primary Completion Date: November 2007 (Final data collection date for primary outcome measure)